ZA90554B - Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions - Google Patents

Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions

Info

Publication number
ZA90554B
ZA90554B ZA90554A ZA90554A ZA90554B ZA 90554 B ZA90554 B ZA 90554B ZA 90554 A ZA90554 A ZA 90554A ZA 90554 A ZA90554 A ZA 90554A ZA 90554 B ZA90554 B ZA 90554B
Authority
ZA
South Africa
Prior art keywords
pyrrole
heteroaryl
alkyl
carboxylic acid
acid compounds
Prior art date
Application number
ZA90554A
Other languages
English (en)
Inventor
Roger Alan Parker
Alan Parker Roger
George Ku
Ku George
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of ZA90554B publication Critical patent/ZA90554B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
ZA90554A 1989-01-31 1990-01-25 Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions ZA90554B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30414189A 1989-01-31 1989-01-31

Publications (1)

Publication Number Publication Date
ZA90554B true ZA90554B (en) 1990-10-31

Family

ID=23175237

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA90554A ZA90554B (en) 1989-01-31 1990-01-25 Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions

Country Status (17)

Country Link
EP (1) EP0381141B1 (de)
JP (1) JP2841305B2 (de)
KR (1) KR0139288B1 (de)
CN (1) CN1022754C (de)
AR (1) AR245694A1 (de)
AT (1) ATE135702T1 (de)
AU (1) AU629290B2 (de)
CA (1) CA2008616C (de)
DE (1) DE69025967T2 (de)
ES (1) ES2087093T3 (de)
FI (1) FI900464A0 (de)
HU (1) HU209290B (de)
IL (1) IL93187A (de)
NO (1) NO174887C (de)
NZ (1) NZ232278A (de)
PT (1) PT93009A (de)
ZA (1) ZA90554B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
ZA90555B (en) * 1989-01-31 1990-10-31 Merrell Pharma Inc Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions
CA2767112C (en) 2009-07-10 2018-06-19 The General Hospital Corporation Etomidate analogues that do not inhibit adrenocortical steroid synthesis
CN102114430B (zh) * 2009-12-30 2013-06-05 上海睿智化学研究有限公司 催化剂、其制备方法及n-烷基吡咯衍生物的制备方法
ES2617536T3 (es) 2012-01-13 2017-06-19 The General Hospital Corporation Compuestos anestésicos y métodos relacionados de uso

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112112A (en) * 1976-06-29 1978-09-05 Merck & Co., Inc. Pyrrolo[2,1-b] [3]benzazepines useful for producing a skeletal muscle relaxing or tranquilizing effect
JPS54128567A (en) * 1978-03-28 1979-10-05 Teijin Ltd 1-substituted-4-acyl-2-pyrrolecarboxylic acid derivative

Also Published As

Publication number Publication date
ES2087093T3 (es) 1996-07-16
CN1022754C (zh) 1993-11-17
HU900592D0 (en) 1990-04-28
ATE135702T1 (de) 1996-04-15
EP0381141A2 (de) 1990-08-08
HU209290B (en) 1994-04-28
JPH02247165A (ja) 1990-10-02
PT93009A (pt) 1990-07-31
AU629290B2 (en) 1992-10-01
IL93187A0 (en) 1990-11-05
EP0381141A3 (de) 1991-11-21
NO174887C (no) 1994-07-27
NO900432D0 (no) 1990-01-30
CA2008616A1 (en) 1990-07-31
AR245694A1 (es) 1994-02-28
FI900464A0 (fi) 1990-01-30
NZ232278A (en) 1992-07-28
IL93187A (en) 1994-12-29
HUT53868A (en) 1990-12-28
KR900011725A (ko) 1990-08-02
JP2841305B2 (ja) 1998-12-24
CN1044653A (zh) 1990-08-15
EP0381141B1 (de) 1996-03-20
AU4875990A (en) 1990-08-09
DE69025967D1 (de) 1996-04-25
CA2008616C (en) 2000-07-18
NO900432L (no) 1990-08-01
KR0139288B1 (ko) 1998-05-15
NO174887B (no) 1994-04-18
DE69025967T2 (de) 1996-08-29

Similar Documents

Publication Publication Date Title
YU205188A (en) Process for reducing arising leaves in process of alpha-olephine polymerisation
EP0234726A3 (en) Methacrylate resin composition and process for its preparation
ZA895512B (en) Fatty acid composition
ZA883408B (en) Superabsorbent composition and process
EP0280173A3 (en) Radical polymerizable composition
EP0200368A3 (en) Continuous treatment process for polymer compositions
AR241987A1 (es) Una solucion microbiocida liquida, composiciones de polimero que contienen dichas soluciones y procedimiento para impartir propiedades microbiocidas a tales composiciones de polimero.
YU44799B (en) Process for buthadien polymerization in mass
DE3662146D1 (en) Substituted glutaric acid lactones in the treatment of hyperlipidemia
EP0456073A3 (en) Multifunctional compounds having alpha-diazo-beta-ketoester units and sulfonic acid ester units, process for their preparation and their use
ZA90554B (en) Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions
HUT37887A (en) Disinfecting compositions and process for the preparation thereof
HK123396A (en) New broncho-spasmolytic compounds and process for their preparation
ZA876598B (en) Bromofluoroethylhypofluorite and process for its preparation
EP0423686A3 (en) Silacyclobutanes and process for preparation
ZA90555B (en) Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions
EP0300294A3 (en) Novel compound dc-107 and process for its preparation
ZA881170B (en) Compositions and methods for treating wood
GB9000349D0 (en) Piperazinylalkylcarboxylic acid adamantylamides
EP0422439A3 (en) Aminomethanephosphonic acid esters, process for their preparation and their use
GB9004313D0 (en) Conversion composition and process
GB8915932D0 (en) Improvements in or relating to trays
EP0433806A3 (en) Isocyanatoalkylsulfonates and process for their preparation
IL97618A0 (en) Novel benzocycloalkenecarboxylic acid and process for its preparation
CS270390A3 (en) Process for increase in efficiency of coagulation